Disclosures: YouRan Zhao: Nothing to Disclose, Catherine Vincent: Nothing to Disclose, Marc Bilodeau: Mirum Pharmaceuticals: Speaking and Teaching, Pascal Lapierre: Nothing to Disclose, Julian Hercun: Nothing to Disclose 2340 DEEP LEARNING ANALYSIS OF MAGNETIC RESONANCE IMAGING ACCURATELY DETECTS EARLY-STAGE CHOLANGIOCARCINOMA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS Yashbir Singh 1 John Eaton 2 Sudhakar Venkatesh 2 Shahriar Faghani 1 Mette vesterhus 3 Tom Karlsen 4 Kristin Jorgensen 5 Trine Folseraas 4 Kosta Petrovic 6 Anne Negrd 5 Aliya Gulamhusein 7 Gregory Gores 1 Sumera Ilyas 2 Timucin Taner 2 Julie Heimbach 2 Nicholas LaRusso 1 Konstantinos Lazaridis 1 Bradley Erickson 1 , 1 Mayo Clinic - Rochester, 2 Mayo Clinic Rochester, 3 University of Bergen, 4 Oslo University, 5 Akershus University Hospital, 6 Haukeland University, 7 University of Toronto Background: Cholangiocarcinoma (CCA), particularly perihilar CCA (pCCA), is the leading source of mortality among patients with primary sclerosing cholangitis (PSC)
10 It is expressed mainly in pancreatic -cells, various gut-cells, and also in the peripheral nervous system and CNS cells ( Figure 1 )
C., Chen, C., Ligon, B
As the new Alzheimers results show, theres been a disconnect between the outcomes of large studies like these and other evidence pointing to potential benefits
A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans
Johnson, T
